The Scientist

» biotechnology and microbiology

Most Recent

image: Neonatal Gut Bacteria Might Promote Asthma

Neonatal Gut Bacteria Might Promote Asthma

By | September 12, 2016

Byproducts of gut microbes in some 1-month–old babies trigger inflammation that is linked to later asthma development, researchers find.

1 Comment

image: Giant Petri Dish Displays Evolution in Space and Time

Giant Petri Dish Displays Evolution in Space and Time

By | September 8, 2016

As E. coli bacteria spread over increasingly concentrated antibiotics, researchers discover novel evolutionary pathways that confer resistance.

7 Comments

image: Promoting Protein Partnerships

Promoting Protein Partnerships

By | September 1, 2016

Scientists generate new protein-protein interactions at an impressive PACE.

0 Comments

image: Smart Skin Enables Magnetoreception

Smart Skin Enables Magnetoreception

By | September 1, 2016

Researchers develop a wearable technology that can detect magnetic fields and translate the signal into a visual display—a first step toward equipping humans with an entirely new sense.

1 Comment

image: Protein or Perish

Protein or Perish

By | September 1, 2016

A bacteriophage must evolve certain variants of a protein or die.

0 Comments

image: Opinion: Acquiring Extra Senses

Opinion: Acquiring Extra Senses

By | September 1, 2016

Animals’ diverse sensory abilities will guide a technology-based revolution that gives humans perception beyond our natural senses.

1 Comment

image: Exploring Alternative Codon Usage in Yeast

Exploring Alternative Codon Usage in Yeast

By | August 18, 2016

Newly discovered amino acid reassignment could have implications for certain biotech applications and RNA-based evolutionary theories.

0 Comments

image: Antibiotic Resistance Reaches Brazil

Antibiotic Resistance Reaches Brazil

By | August 8, 2016

Scientists detect a colistin-resistance gene in a clinical sample.

0 Comments

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

From sequencing bacteriophages to synthesizing bacterial genomes to defining a minimal genome

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS